Revolutionizing Neurological Care

September 20, 2023

In the rapidly evolving landscape of healthcare technology, TeraRecon has built a global presence through leading advanced visualization solutions. In recent years we have developed cutting-edge AI-empowered solutions with a focus on radiology, cardiology, neurology, oncology, and vascular surgery. Adapting to the evolving needs of the healthcare sector, our portfolio includes the Eureka Clinical AI platform—a platform designed for coordinated care.

Our commitment to neurology shines through in both Neuro Suite and TR Neuro, AI-based solutions available on the Eureka Clinical AI platform, which provide critical data and visualizations for the management of a wide variety neurovascular conditions.

Addressing Critical Challenges in Neurology
A pressing challenge in neurology is the timely diagnosis of conditions like stroke, where every moment counts. TR Neuro rises to this challenge with an AI-powered clinical workflow solution that swiftly detects neurovascular emergencies. This solution, deployable on-site, or in the cloud, is equipped with large vessel occlusion (LVO), intracerebral hemorrhage (ICH), and Alberta Stroke Program Early CT Score (ASPECTS) algorithms, offering a comprehensive patient overview. Additionally, automated computerized tomography (CT) perfusion maps further enhance diagnostic speed.

Validation from 40 U.S. academic centers underscores TR Neuro's reliability. With a 97.7% accuracy rate for LVO detection and a 94% accuracy rate for ICH identification, TR Neuro emerges as a game-changer. The inclusion of automated CT perfusion maps offers seven customizable perfusion maps to aid medical professionals’ speed in decision making. TR Neuro's integration into desktop viewers and mobile applications ensures physicians have direct interaction with AI insights, thus maintaining control over patient records.

Collaborative Care for Optimal Outcomes
Collaboration gaps within the healthcare continuum often hinder efficient care delivery, especially in cases of neurovascular diseases. TR Neuro takes a proactive stance by facilitating streamlined workflows and standardized care through its customizable platform. By incorporating HIPAA-compliant communication tools like instant messaging, group chat, and patient-level chat, TR Neuro fosters seamless communication and coordination among care teams.

Empowering Clinicians with Control
A hallmark of our AI solutions is the empowerment of clinicians in the diagnostic process. TR Neuro's physician-controlled AI experience allows clinicians to interact with AI algorithms, enhancing their outputs. The seamless integration of our solutions into existing technologies ensures a smooth transition. Physicians can accept, reject, or re-run AI-generated insights, ensuring that clinical preferences and judgments remain central to patient care.

The Eureka of AI Solutions
The Eureka Clinical AI platform stands as a testament to our commitment to innovation. By supporting a wide array of AI algorithms, the platform tailors multi-AI model workflows according to healthcare facility needs. This flexibility empowers care teams to receive timely results and alerts, significantly impacting patient care.

Partnerships Paving the Way
Our collaborations extend our reach even further, including partnering with Combinostics, Imaging Biometrics, and Cercare Medical for our Neuro Suite. Combinostics' expertise in automatic labeling, quantification, and visualization of segmentable brain structures, Imaging Biometrics' technological prowess have magnified our collective potential, and Cercare Medical, a provider of perfusion software to enhance MR and CT imaging underscoring our commitment to holistic solutions. 

Commitment to Excellence and Security
A commitment to excellence is epitomized by consistent updates and enhanced versions. This commitment recently led to our ISO 27001:2022 certification, affirming our dedication to patient data security and information infrastructure.

Recognized Leadership in the Field
For our unwavering dedication to providing advanced, secure, and collaborative AI-based neurological solutions, we have been recognized by Frost & Sullivan as the 2023 Global Company of the Year in the AI-based neurological solutions industry. This accolade acknowledges our high growth potential and pivotal role in shaping the future of neurological care.

Conclusion: A Bright Future Ahead
Our journey, from inception to our current standing as a global leader in AI-based neurological solutions, is a testament to our unwavering commitment to innovation and excellence. By addressing critical challenges in neurology, fostering collaborative care, and empowering clinicians, we have transformed the landscape of neurovascular condition management. With our Eureka Clinical AI platform, strategic partnerships, and unyielding dedication to security, we will continue to revolutionize the approach to neurological care.

You May Also Like

These Stories on Artificial Intelligence

Subscribe by Email

No Comments Yet

Let us know what you think